Understand the source comparison
SS-LUP-332 Comparison: Mechanism vs Reported Outcomes
The following table compares SS-LUP-332's theoretical mechanism to what reddit community reviews actually report, alongside related metabolic research compounds. SS-LUP-332 ERRα/ERRγ agonist; upregulates PGC-1α and mitochondrial biogenesis Increased fat oxidat
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The following table compares SS-LUP-332's theoretical mechanism to what reddit community reviews actually report, alongside related metabolic research compounds.
- SS-LUP-332
- ERRα/ERRγ agonist; upregulates PGC-1α and mitochondrial biogenesis
- Increased fat oxidation, enhanced endurance, improved insulin sensitivity
- Minimal metabolic change at 5–20mg daily over 8–12 weeks; no consistent fat loss or endurance gain
- Likely underdosed relative to receptor occupancy requirements; mechanism requires chronic exposure at unknown therapeutic threshold
- Cardarine (GW501516)
- PPARδ agonist; increases fatty acid oxidation and glucose uptake in muscle
- Enhanced endurance, fat loss during caloric deficit
- Consistent reports of endurance improvement at 10–20mg daily; modest fat loss when combined with deficit
- Effective at commonly used doses but withdrawn from clinical development due to cancer findings in rodent studies at high doses
- SR9009
- REV-ERB agonist; regulates circadian rhythm and lipid metabolism
- Increased metabolic rate, fat loss without stimulant effects
- Mixed reports; oral bioavailability questioned; subcutaneous injection reportedly more effective
- Poor oral bioavailability limits efficacy; injectable protocols show better subjective outcomes but lack pharmacokinetic validation
- AICAR
- AMPK activator; mimics exercise-induced metabolic signalling
- Increased glucose uptake, fat oxidation, mitochondrial biogenesis
- Gastrointestinal side effects common at effective doses (500mg+); inconsistent metabolic benefits
- Effective in animal models but human doses required for metabolic effects approach tolerability limits